LumiThera

Poulsbo, United States Founded: 2013 • Age: 13 yrs Acquired By Alcon
Photobiomodulation treatments for ocular diseases are developed.
Request Access

About LumiThera

LumiThera is a company based in Poulsbo (United States) founded in 2013 by James Carroll, Luis De Taboada, Graham Merry, and Clark E Tedford was acquired by Alcon in September 2025.. LumiThera has raised $35.33 million across 16 funding rounds from investors including Alcon, Nikon and NIH. The company has 18 employees as of December 31, 2022. LumiThera has completed 1 acquisition, including Diopsys. LumiThera offers products and services including Valeda Light Delivery System.

  • Headquarter Poulsbo, United States
  • Employees 18 as on 31 Dec, 2022
  • Founders James Carroll, Luis De Taboada, Graham Merry, Clark E Tedford
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Lumithera, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $35.33 M (USD)

    in 16 rounds

  • Latest Funding Round
    $10 M (USD), Series D

    May 08, 2024

  • Investors
    Alcon

    & 12 more

  • Employee Count
    18

    as on Dec 31, 2022

  • Investments & Acquisitions
  • Acquired by
    Alcon

    (Sep 05, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of LumiThera

LumiThera offers a comprehensive portfolio of products and services, including Valeda Light Delivery System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for treating dry AMD by improving visual acuity through photobiomodulation.

People of LumiThera
Headcount 10-50
Employee Profiles 15
Board Members and Advisors 3
Employee Profiles
People
Scott Bradley
Vice President, Product Development
People
Duane R. Morrison
VP, Sales
People
Robert J. Bard
VP, Quality & Regulatory Affairs
People
Clark E. Tedford
Co-Founder, President & CEO

Unlock access to complete

Board Members and Advisors
people
Carina Cao
Board Observer
people
Daniel Bertholet
Board Member
people
Yang Yigang
Board Member

Unlock access to complete

Funding Insights of LumiThera

LumiThera has successfully raised a total of $35.33M across 16 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 16
  • Last Round Series D — $10.0M
  • First Round
  • Investors Count 12
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2024 Amount Series D - LumiThera Valuation

investors

Sep, 2022 Amount Series C - LumiThera Valuation

investors

Sep, 2022 Amount Grant - LumiThera Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in LumiThera

LumiThera has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Alcon, Nikon and NIH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity investments are managed in the United States.
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by LumiThera

LumiThera has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Diopsys. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Non-invasive visual electrophysiology devices are supplied for ophthalmological diagnosis.
2002
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - LumiThera

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lumithera Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of LumiThera

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lumithera

Frequently Asked Questions about LumiThera

When was LumiThera founded?

LumiThera was founded in 2013.

Where is LumiThera located?

LumiThera is headquartered in Poulsbo, United States. It is registered at Poulsbo, Washington, United States.

Who is the current CEO of LumiThera?

Clark E Tedford is the current CEO of LumiThera. They have also founded this company.

Is LumiThera a funded company?

LumiThera is a funded company, having raised a total of $35.33M across 16 funding rounds to date. The company's 1st funding round was a Grant of $1.81M, raised on Jun 01, 2013.

How many employees does LumiThera have?

As of Dec 31, 2022, the latest employee count at LumiThera is 18.

What does LumiThera do?

Founded in 2013 and headquartered in Poulsbo, United States, the company operates in the medical device sector. Photobiomodulation therapies for ocular conditions, including dry age-related macular degeneration, are developed through devices such as the Valeda light delivery system. LED and laser technologies are utilized in these non-invasive treatments to address various eye diseases. Operations focus on research, device manufacturing, and clinical applications in ophthalmology.

What products or services does LumiThera offer?

LumiThera offers Valeda Light Delivery System.

How many acquisitions has LumiThera made?

LumiThera has made 1 acquisition, including Diopsys.

Who are LumiThera's investors?

LumiThera has 13 investors. Key investors include Alcon, Nikon, NIH, HHS, and Keiretsu Forum.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available